Responses
Clinical and epidemiological research
Extended report
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial
Compose a Response to This Article
Other responses
No responses have been published for this article.